COMMUNIQUÉS West-GlobeNewswire

Brown’s Medical Imaging and Prestige Medical Imaging Merge, Expanding Nationwide Service Capabilities
25/11/2025
Combined platform strengthens national footprint, enhances multi-vendor service expertise, and accelerates customer-first innovation OMAHA, Neb., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Brown’s Medical Imaging (“Brown’s” or [...]
Health Care Resource Centers Appoints Dr. Katherine Krauskopf as Regional Medical Director in Western Massachusetts
25/11/2025
To lead addiction treatment programs across Greenfield, Westfield, Northampton, and Chicopee CHICOPEE, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Health Care Resource Centers (HCRC), a BayMark Health Services company, has [...]
Branded Legacy Announces Strong Revenues from Newly Acquired Pau Hana Subsidiary
25/11/2025
Pau Hana Plans Ambitious Expansion Roadmap and New Location Acquisitions in the Pipeline MELBOURNE, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC:BLEG), a leader in innovative addiction [...]
LifeLabs Donates $10,000 to Women in Crisis in Honour of the International Day for the Elimination of Violence Against Women and Girls.
25/11/2025
Proud to Support a Foundation for a World Free of Gender-Based Violence Toronto, Ontario, Nov. 25, 2025 (GLOBE NEWSWIRE) -- LifeLabs, Canada's leading provider of medical diagnostic services, is proud to donate $10,000 [...]
BioStem Technologies Expands Product Access in Medicaid
25/11/2025
Florida Medicaid Adds BioStem’s VENDAJE® and VENDAJE AC® to Covered Skin Substitutes List POMPANO BEACH, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company [...]
Foundation for Sarcoidosis Research Convenes Global Leaders for Landmark Clinic Alliance Meeting and Sarcoidosis Biomarker Summit
25/11/2025
CHICAGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) brought together more than 40 leading clinicians and researchers from around the world for two landmark events: the inaugural in- [...]
Prenetics Announces Upcoming Conference Participation
25/11/2025
CHARLOTTE, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today [...]
Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference
25/11/2025
Live webcast fireside chat on Thursday, December 4 th at 10:30 AM ET Carlsbad, CA, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical [...]
Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025
25/11/2025
Seven posters to be presented, including new X-TOLE OLE data supporting the ability to attain and regain extended periods of seizure freedom with long-term use of azetukalner Data will also highlight the impact of [...]
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access
25/11/2025
Company to advance care through broader access to breadth of skin substitutes across four unique technology platforms PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq [...]
Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program
25/11/2025
BOSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies, today announced that its [...]
Lexicon Pharmaceuticals to Participate in Two Upcoming December Investor Conferences
25/11/2025
THE WOODLANDS, Texas, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the Piper Sandler 37th Annual [...]
PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025
25/11/2025
Internationally recognized colorectal surgeon Steven D. Wexner, MD, FACS, FRCS, to discuss the clinical and economic burden of surgical site infections and the therapeutic potential of D-PLEX₁₀₀ PETACH TIKVA, Israel, [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Anticipates Major Fair-Value Uptick Following New Independent JV Valuation
25/11/2025
NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- via BioMedWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic [...]
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment
25/11/2025
Located at the Daresbury site of the renowned UK-based Science and Technology Facilities Council (STFC), with $300+ million invested to date in developing the technology BOCA RATON, Fla., Nov. 25, 2025 (GLOBE NEWSWIRE [...]
Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS
25/11/2025
Publication details large multicenter clinical trial demonstrating significant reductions in IBS symptoms through inFoods IBS guided dietary therapy IRVINE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. ( [...]
Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®
25/11/2025
Following the positive opinions of the Committee for Medicinal Products for Human Use (CHMP ) , the European Commission has granted marketing authorizations for Teva’s biosimilars PONLIMSI and DEGEVMA expanding access [...]
Nanox Engages with Althea France to Accelerate European Commercialization of Nanox.ARC System
25/11/2025
Althea France, part of one of Europe's largest independent medical technology services provider s , to distribute CE-marked Nanox.ARC system across French healthcare sector Partnership represents Nanox's fourth European [...]
UroGen Pharma to Present at the Piper Sandler 37th Annual Healthcare Conference
25/11/2025
PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today [...]

Pages